Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: September 26, 2022

Details for Patent: 6,803,376

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 6,803,376
Title: Method of use of quinolone compounds against pneumococcal and haemophilus bacteria
Abstract:This invention relates, in part, to newly identified methods of using quinolone antibiotics, particularly a gemifloxacin compound against certain pathogenic bacteria, particularly quinolone resistant S. pnemoniae and rare H. influenzae strains.
Inventor(s): Appelbaum; Peter C. (Hershey, PA), Credito; Kim L. (Hershey, PA), Davies; Todd (Hershey, PA), Hoellman; Diane B. (Hershey, PA), Kelly; Linda M. (Hershey, PA), Pankuch; Glenn A. (Hershey, PA)
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Application Number:09/569,648
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 6,803,376

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,803,376

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 383157 See Plans and Pricing
Australia 6201600 See Plans and Pricing
Canada 2281817 See Plans and Pricing
Canada 2282066 See Plans and Pricing
Canada 2283141 See Plans and Pricing
Canada 2283352 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.